How much does canakinumab cost? Where to buy?

Novartis said the European Union has approved its drug canakinumab for the treatment of patients with acute gouty arthritis who cannot tolerate other treatment options. Canakinumab is the first biologic approved by the European Union for the relief of pain during the onset of gouty arthritis symptoms. The drug is administered as a single dose, subcutaneously. The drug blocks interleukin-1β, a protein thought to increase inflammation, and is already on the market to treat Cryopyrin-associated periodic syndrome, a rare inflammatory disease. In 2011, the U.S. drug regulatory agency refused to approve canakinumab for the treatment of gout due to adverse reactions.

Canakinumab side effects: decreased calcium, diarrhea, gastroenteritis, increased bilirubin, musculoskeletal pain, influenza, nausea, pharyngitis, rhinitis, weight gain, dizziness, increased eosinophils, increased ALT (alanine aminotransferase), nasopharyngitis, creatinine clearance, bronchitis, headache, injection site pain, proteinuria, etc.

How much does canakinumab cost? Where to buy? Canakinumab is not available in China because the drug is not on the market, so there is no price, let alone the cost of traveling abroad. Most patients think that the only way to purchase canakinumab is to purchase the drug overseas, but this method is more expensive and requires a long round trip, which puts a considerable burden on the patient's family. At this time, patients can choose the domestic and overseas medical service organization Medical Companion Travel to help them purchase drugs overseas. On the one hand, the price of canakinumab purchased by Medical Companion Travel is more affordable. On the other hand, the method of purchasing medicine through Medical Companion Travel is very safe. Direct mail overseas, and the medicines are delivered directly to patients. They are 100% authentic. For details, please contact Medical Companion Travel to answer your questions.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.